Trial intelligence / Profile preview

Desogestrel vs depot medroxyprogesterone acetate on bone markers in reproductive-aged women

TCTR20240628006Unknown

Sponsor
Chiang Mai University
Start
Oct 2023
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Trial of desogestrel and medroxyprogesterone acetate in osteoporosis and None (2 arms), sponsored by Chiang Mai University. Primary endpoint: Change in bone markers between desogestrel and DMPA groups. Status: unknown.

02

Drugs

desogestrelmedroxyprogesterone acetate
03

Conditions

osteoporosis

Beyond the preview

Go deeper on TCTR20240628006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240628006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call